Private-label OTCs making a dent in brand-name share

March 20, 2006

The market for private-label OTC drugs is expected to reach $3.6 billion by 2010, according to a new study by Kalorama Information, a division of MarketResearch.com. The study found that private-label brands ate up 19.7% of the OTC market share in 2004, with sales topping $3.4 billion in 2005.

Private-label OTCs making a dent in brand-name share

The market for private-label OTC drugs is expected to reach $3.6 billion by 2010, according to a new study by Kalorama Information, a division of http://MarketResearch.com/. The study found that private-label brands ate up 19.7% of the OTC market share in 2004, with sales topping $3.4 billion in 2005. The market was buoyed by growing sales in the cough, cold, allergy, sinus, first-aid, and antismoking sectors.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.